CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
Ji-Yeon Lee, Eun Seok Kang
Diabetes Metab J. 2019;43(3):379-380.   Published online June 13, 2019
DOI: https://doi.org/10.4093/dmj.2018.0106

Excel Download

Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
Diabetes & Metabolism Journal. 2019;43(3):379   Crossref logo
Link1 Link2 Link3

Letter: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
Diabetes & Metabolism Journal. 2019;43(3):377   Crossref logo
Link1 Link2 Link3

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
Diabetes & Metabolism Journal. 2019;43(2):158   Crossref logo
Link1 Link2 Link3

Potential for combination of dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors for the treatment of type 2 diabetes
Diabetes, Obesity and Metabolism. 2015;17(7):616-621   Crossref logo
Link1 Link2 Link3 Link4

Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus
Diabetes, Obesity and Metabolism. 2013;15(5):392-402   Crossref logo
Link1 Link2

A safety update on sodium glucose co‐transporter 2 inhibitors
Diabetes, Obesity and Metabolism. 2019;21(S2):34-42   Crossref logo
Link1 Link2 Link3 Link4

Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9)
Diabetes & Metabolism Journal. 2019;43(6):915   Crossref logo
Link1 Link2 Link3

Sodium‐glucose co‐transporter inhibitors: Medications that mimic fasting for cardiovascular prevention
Diabetes, Obesity and Metabolism. 2019;21(10):2211-2218   Crossref logo
Link1 Link2 Link3 Link4

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes
International Journal of Clinical Practice. 2008;62(8):1279-1284   Crossref logo
Link1 Link2

Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes?
Diabetes, Obesity and Metabolism. 2018;21(2):207-209   Crossref logo
Link1 Link2